• AT13387: Hsp90 Inhibition Redefines Cell Death in Oncology

  2026-06-01

  Explore how AT13387, a next-generation Hsp90 inhibitor from APExBIO, enables translational cancer researchers to interrogate the molecular logic of apoptosis, cell cycle arrest, and oncogenic signaling. This article synthesizes mechanistic breakthroughs—such as NINJ1-mediated DAMP secretion—with experimental strategy, competitive context, and forward-looking guidance, advancing beyond the typical product narrative.

• SP1/ADAM10/DRP1 Axis in Hypoxia-Induced Pulmonary Hypertensi

  2026-06-01

  The referenced study uncovers a mechanistic pathway linking SP1, ADAM10, and DRP1 in mediating endothelial to smooth muscle cell communication under hypoxic conditions in pulmonary hypertension. These findings provide new insight into cellular interplay and signal transduction driving vascular remodeling, with implications for therapeutic targeting in hypoxia-induced pulmonary hypertension.

• Technical Guide: 4-Hydroxytamoxifen in Research Workflows

  2026-05-31

  4-Hydroxytamoxifen (SKU B6167) provides a high-purity, DMSO-soluble estrogen receptor modulator for specialized breast cancer, prostate cancer, and cardiac myocyte studies. It is unsuitable for protocols requiring aqueous or ethanol-based preparations and demands precise storage to ensure experimental reproducibility.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Precision in Proteom

  2026-05-30

  Explore how the Cy3 Goat Anti-Mouse IgG (H+L) Antibody enables ultra-sensitive mouse IgG detection in advanced proteomics and biomarker discovery. This article delves into its unique role, mechanism, and assay optimization, offering a fresh perspective beyond standard immunofluorescence applications.

• Oridonin Suppresses Esophageal Cancer via Inflammation Modul

  2026-05-29

  Peng et al. (2025) provide compelling evidence that oridonin inhibits esophageal cancer progression by targeting the TLR4/NF-κB/NLRP3 inflammasome pathway in a murine model. This mechanistic insight clarifies the interplay between chronic inflammation and tumorigenesis, informing the development of preclinical anti-inflammatory cancer strategies.

• 2-Deoxy-D-glucose (SKU B1027): Precision Glycolysis Inhibiti

  2026-05-29

  This scenario-driven guide explores how 2-Deoxy-D-glucose (SKU B1027) from APExBIO enhances reproducibility and sensitivity in cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed literature and quantifiable data, the article addresses common experimental pitfalls and demonstrates how B1027 supports robust metabolic pathway studies, especially in cancer and virology research.

• Perphenazine: Advancing Neuropharmacology and Host Immunity

  2026-05-28

  This thought-leadership article explores the mechanistic landscape and translational potential of Perphenazine as a dopamine D2 receptor antagonist, bridging neuroscience, psychosis treatment research, and emerging host-directed antibacterial strategies. Drawing from recent mechanistic studies, competitive analyses, and protocol guidance, it empowers translational researchers to leverage APExBIO’s Perphenazine for advanced neuropharmacology and immunomodulation workflows.

• A 83-01: ALK-5 Inhibitor Workflows for Organoid and EMT Rese

  2026-05-28

  A 83-01’s selective ALK-5 inhibition enables precise dissection of TGF-β/Smad signaling in organoid, EMT, and growth regulation assays. This guide provides actionable protocols, troubleshooting strategies, and contextualizes the latest liver organoid modeling innovations for advanced disease research.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Practical Lab Guide

  2026-05-27

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive fluorescence-based detection of goat primary antibodies in ICC, IHC, flow cytometry, and ELISA workflows. It should be used only where goat IgG is the primary target; cross-reactivity with non-goat primaries or unvalidated protocols is not supported. Proper handling and workflow alignment are essential to maximize signal quality and minimize background.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-05-27

  This study provides a comprehensive molecular and epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China (2022–2024). The findings highlight a high prevalence of plasmid-borne blaNDM-1 and demonstrate both vertical and horizontal gene transfer, underscoring critical challenges for antibacterial research and infection control.

• EPI-001: Advancing AR N-Terminal Inhibition in Translational

  2026-05-26

  This article explores the mechanistic and translational significance of EPI-001—a pioneering androgen receptor N-terminal domain inhibitor—across prostate and triple-negative breast cancer models. By weaving together recent mechanistic discoveries, experimental validation, and strategic workflow guidance, it offers translational researchers actionable insights and forward-thinking perspectives, distinguishing itself from conventional product summaries.

• Sodium, Mitochondria, and Translational Strategy: TMRE in Ac

  2026-05-26

  A thought-leadership exploration of sodium-driven mitochondrial dysfunction, integrating mechanistic insight from recent NECSO research with actionable guidance for translational investigators. This article elevates the discussion beyond standard TMRE assay protocols, strategically positioning the APExBIO TMRE mitochondrial membrane potential assay kit as an indispensable tool for decoding cell fate mechanisms and advancing disease modeling.

• CPI-613 in Cancer Research: Mitochondrial Metabolism and Cel

  2026-05-25

  Discover how CPI-613, a cutting-edge pyruvate dehydrogenase complex inhibitor, enables advanced investigation of mitochondrial metabolism and apoptosis in cancer cells. This article uniquely integrates CPI-613’s mechanistic depth with fresh insights from recent mitochondrial calcium signaling research.

• 7-Ethyl-10-hydroxycamptothecin: Precision Workflows in Colon

  2026-05-25

  Unlock dual pathway modulation in advanced colon cancer models with 7-Ethyl-10-hydroxycamptothecin. This guide delivers stepwise protocols, troubleshooting tips, and insights from the latest reference study, empowering researchers to drive reproducible, high-impact apoptosis and cell cycle assays.

• Deferiprone (SKU B1723): Optimizing Iron Modulation in Cell

  2026-05-24

  This article addresses real laboratory challenges in iron-dependent assays by highlighting how Deferiprone (SKU B1723) enables reproducible, mechanistically informed research in cell viability, proliferation, and cytotoxicity workflows. Through scenario-driven Q&A, it demonstrates the advantages of Deferiprone for apoptosis induction, protection against doxorubicin-induced cytotoxicity, and iron metabolism studies, with actionable guidance for biomedical researchers.

16359 records 1/1091 page Next 12345 下5页 Last page